Robert H. Lurie Cancer Center
22
1
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
36.4%
8 terminated/withdrawn out of 22 trials
52.9%
-33.6% vs industry average
0%
0 trials in Phase 3/4
89%
8 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Lymphedema Sensor Technology Development Study
Role: collaborator
Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia
Role: collaborator
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
Role: collaborator
Reducing Emotional Distress, Enhancing Function and Improving Network Engagement in Adolescent and Young Adult Oncology
Role: collaborator
Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
Role: collaborator
Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Role: collaborator
A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
Role: collaborator
Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Role: collaborator
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Role: collaborator
Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Role: collaborator
Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL
Role: collaborator
Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Role: collaborator
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
Role: collaborator
Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer
Role: collaborator
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Role: lead
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
Role: lead
Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome
Role: collaborator
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Role: collaborator
Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making
Role: collaborator
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
Role: lead